Loading organizations...
BacAlt Biosciences is a Bengaluru, India-based biotechnology startup that develops bio-based polymers from agricultural waste and post-harvest crop residues. The company utilizes proprietary fermentation platforms to convert these agricultural byproducts into cost-efficient material alternatives that replace traditional petrochemical and synthetic inputs. These specialty ingredients are designed for fast-moving consumer goods and chemical applications across the personal care, home care, textile, agrochemical, nutraceutical, and pharmaceutical sectors. In October 2025, the pre-seed stage company raised $2.1 million in funding, reaching an $8 million valuation, to scale its research and development processes and build pilot production facilities. This recent financing round was led by venture capital firm Avaana Capital, with additional strategic participation from corporate investor Lubrizol InnoVentures. BacAlt Biosciences was founded in 2023 by Shruti Kutmutia, Pranav Nair, Madhav Sethia, and Mayank Ketan Kutmutia.
BacAlt has raised $4.1M across 3 funding rounds.
BacAlt has raised $4.1M in total across 3 funding rounds.
BacAlt has raised $4.1M across 3 funding rounds. Most recently, it raised $2.0M Decnut - Pre-Seed in September 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 11, 2025 | $2M Pre Seed | Shefalika Shekhawat | John Patrin | Announced |
| Sep 1, 2025 | $2M Seed | — | Avaana Capital, Babel Ventures, Techstars, Oliver Stahl | Announced |
| Apr 18, 2015 | $50K Venture Round | BEN Franklin Technology Partners | — | Announced |
BacAlt Biosciences is a Bengaluru-based cleantech startup founded in 2023 that develops sustainable biopolymers, such as bacterial cellulose and poly gamma glutamic acid, by transforming post-harvest crop residues into advanced, bio-based materials.[1][2][3] These eco-friendly alternatives replace harmful petrochemicals and microplastics, serving industries like cosmetics (skincare, haircare, wound care), textiles, agriculture, home care, personal care, agrochemicals, nutraceuticals, and pharmaceuticals.[1][3][4] The company solves the problem of agricultural waste pollution and import dependency by using energy-efficient fermentation and circular feedstocks for cost-competitive, high-performance ingredients, with recent INR 18 crore (~$2.1M) funding from Avaana Capital and Lubrizol InnoVentures fueling R&D, pilot production, team growth, and global expansion.[1][3][4]
BacAlt Biosciences was founded in 2023 by Shruti Kutmutia (also listed as Shruti Ketan Kutmutia), Pranav Nair, and potentially Madhav Sethia and Mayank Ketan Kutmutia, though sources vary slightly on the exact founder lineup.[1][2] The idea emerged from addressing India's abundant post-harvest crop residues—often wasted or burned—through biotech innovation to create value-added biopolymers, positioning the country as a bio-manufacturing hub.[1][2] Early traction came swiftly with a pre-seed round culminating in the October 2025 INR 18 crore raise, led by Avaana Capital and joined by Lubrizol InnoVentures, validating their proprietary fermentation platform amid rising demand for sustainable materials.[1][3][4]
BacAlt rides the global surge in circular economy and sustainable materials, driven by regulations curbing microplastics (e.g., EU bans) and consumer demand for green alternatives in FMCG and cleantech.[1][4] Timing is ideal amid climate pressures and India's agricultural waste crisis—over 500 million tons annually—turning liability into export opportunity as bio-manufacturing grows at 15-20% CAGR.[1] Market forces like rising petrochemical costs and supply chain vulnerabilities favor localized, waste-based production, while BacAlt influences the ecosystem by accelerating India's shift from import reliance to a hub for bio-based ingredients, partnering with giants like Lubrizol for global reach.[1][4]
BacAlt is poised for rapid scaling post-funding, with pilot facilities and international strategies targeting high-growth sectors like personal care and agriculture, potentially capturing share from incumbents via cost-effective biotech.[1][3] Trends like AI-optimized fermentation, stricter sustainability mandates, and biotech M&A will shape its path, evolving its influence from niche innovator to key supplier in global circular supply chains—echoing its mission to power bio-manufacturing leadership.[1][4]
BacAlt has raised $4.1M in total across 3 funding rounds.
BacAlt's investors include Shefalika Shekhawat, John Patrin, Avaana Capital, Babel Ventures, Techstars, Oliver Stahl, Ben Franklin Technology Partners.
